tetano
Editor, Senior Moderator
Int J Med Microbiol. 2014 Dec 18. pii: S1438-4221(14)00163-5. doi: 10.1016/j.ijmm.2014.12.004. [Epub ahead of print]
[h=1]Antipneumococcal activity of neuraminidase inhibiting artocarpin.[/h] Walther E[SUP]1[/SUP], Richter M[SUP]1[/SUP], Xu Z[SUP]1[/SUP], Kramer C[SUP]2[/SUP], von Grafenstein S[SUP]2[/SUP], Kirchmair J[SUP]3[/SUP], Grienke U[SUP]4[/SUP], Rollinger JM[SUP]5[/SUP], Liedl KR[SUP]2[/SUP], Slevogt H[SUP]6[/SUP], Sauerbrei A[SUP]1[/SUP], Saluz HP[SUP]7[/SUP], Pfister W[SUP]8[/SUP], Schmidtke M[SUP]9[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Streptococcus (S.) pneumoniae is a major cause of secondary bacterial pneumonia during influenza epidemics. Neuraminidase (NA) is a virulence factor of both pneumococci and influenza viruses. Bacterial neuraminidases (NAs) are structurally related to viral NA and susceptible to oseltamivir, an inhibitor designed to target viral NA. This prompted us to evaluate the antipneumococcal potential of two NA inhibiting natural compounds, the diarylheptanoid katsumadain A and the isoprenylated flavone artocarpin. Chemiluminescence, fluorescence-, and hemagglutination-based enzyme assays were applied to determine the inhibitory efficiency (IC[SUB]50[/SUB] value) of the tested compounds towards pneumococcal NAs. The mechanism of inhibition was studied via enzyme kinetics with recombinant NanA NA. Unlike oseltamivir, which competes with the natural substrate of NA, artocarpin exhibits a mixed-type inhibition with a K[SUB]i[/SUB] value of 9.70μM. Remarkably, artocarpin was the only NA inhibitor (NAI) for which an inhibitory effect on pneumococcal growth (MIC: 0.99-5.75μM) and biofilm formation (MBIC: 1.15-2.97μM) was observable. In addition, we discovered that the bactericidal effect of artocarpin can reduce the viability of pneumococci by a factor of >1000, without obvious harm to lung epithelial cells. This renders artocarpin a promising natural product for further investigations.
Copyright ? 2014 Elsevier GmbH. All rights reserved.
[h=4]KEYWORDS:[/h] Antipneumococcal; Artocarpin; Biofilm; DANA; Katsumadain A; NanA; Neuraminidase; Neuraminidase inhibitors; Oseltamivir; Pneumococci; Zanamivir
PMID: 25592264 [PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/25592264
[h=1]Antipneumococcal activity of neuraminidase inhibiting artocarpin.[/h] Walther E[SUP]1[/SUP], Richter M[SUP]1[/SUP], Xu Z[SUP]1[/SUP], Kramer C[SUP]2[/SUP], von Grafenstein S[SUP]2[/SUP], Kirchmair J[SUP]3[/SUP], Grienke U[SUP]4[/SUP], Rollinger JM[SUP]5[/SUP], Liedl KR[SUP]2[/SUP], Slevogt H[SUP]6[/SUP], Sauerbrei A[SUP]1[/SUP], Saluz HP[SUP]7[/SUP], Pfister W[SUP]8[/SUP], Schmidtke M[SUP]9[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Streptococcus (S.) pneumoniae is a major cause of secondary bacterial pneumonia during influenza epidemics. Neuraminidase (NA) is a virulence factor of both pneumococci and influenza viruses. Bacterial neuraminidases (NAs) are structurally related to viral NA and susceptible to oseltamivir, an inhibitor designed to target viral NA. This prompted us to evaluate the antipneumococcal potential of two NA inhibiting natural compounds, the diarylheptanoid katsumadain A and the isoprenylated flavone artocarpin. Chemiluminescence, fluorescence-, and hemagglutination-based enzyme assays were applied to determine the inhibitory efficiency (IC[SUB]50[/SUB] value) of the tested compounds towards pneumococcal NAs. The mechanism of inhibition was studied via enzyme kinetics with recombinant NanA NA. Unlike oseltamivir, which competes with the natural substrate of NA, artocarpin exhibits a mixed-type inhibition with a K[SUB]i[/SUB] value of 9.70μM. Remarkably, artocarpin was the only NA inhibitor (NAI) for which an inhibitory effect on pneumococcal growth (MIC: 0.99-5.75μM) and biofilm formation (MBIC: 1.15-2.97μM) was observable. In addition, we discovered that the bactericidal effect of artocarpin can reduce the viability of pneumococci by a factor of >1000, without obvious harm to lung epithelial cells. This renders artocarpin a promising natural product for further investigations.
Copyright ? 2014 Elsevier GmbH. All rights reserved.
[h=4]KEYWORDS:[/h] Antipneumococcal; Artocarpin; Biofilm; DANA; Katsumadain A; NanA; Neuraminidase; Neuraminidase inhibitors; Oseltamivir; Pneumococci; Zanamivir
PMID: 25592264 [PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/25592264